Medical Digest & Congress Report

Professor Vera Bittner shares her experiences in patient engagement in lipid-lowering therapies. Video: https://medicaldigest.org/scientific-contents/interview:patient-engagement-lipid-lowering-therapies

Professor Piotr Ponikowski shares his experiences on ESC Clinical Practice Guidelines in implementing the 2023 Focused Update on Heart Failure. Video: https://medicaldigest.org/scientific-contents/interview:guidelines-practice-implementing-2023-focused-update-heart-failure-target-treat-and-titrate

Professor Claudio Borghi shares his insights on cardiovascular multimorbid patients’ care. Video: https://medicaldigest.org/scientific-contents/interview:cardiovascular-multimorbid-patients-care-report-esc2024

Professor Isabelle C. Van Gelder co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Atrial Fibrillation. Video: https://medicaldigest.org/scientific-contents/interview:2024-esc-guidelines-management-atrial-fibrillation-report-esc2024

Professor Christiaan Vrints co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. Video: https://medicaldigest.org/scientific-contents/interview:2024-esc-guidelines-management-chronic-coronary-syndromes-report-esc2024

Professor Gi-Byoung Nam explains thtat edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation and stable coronary artery disease, according to late-breaking research presented in a Hot Line session at ESC Congress 2024. Video: https://medicaldiges...

Professor Muthiah Vaduganathan explains that the FINE-HEART pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session at ESC Congress 2024. Video: https://medicaldi...

Professor Mario Marzilli highlights the evolving environment of chronic coronary syndrome management and translates new ESC chronic coronary syndrome guidelines into clinical practice. Video: https://medicaldigest.org/scientific-contents/interview:chronic-ischaemic-syndrome-management-2024-are-we-ready-revolution-report-esc2024

Professor Pardeep Jhund explains that mineralocorticoid receptor antagonists reduced the risk of cardiovascular death or heart failure hospitalization in patients with HF and reduced ejection fraction and also in those with mildly reduced or preserved ejection fraction, according to late-breaking research presented in a Hot Line session at ESC Congress 2024. Video: https://medicaldigest.org/scient...

Professor Ramzi Ajjan shares his insights on cardio-renal protection in patients with diabetes. Video: https://medicaldigest.org/scientific-contents/interview:guidelines-practice-cardio-renal-protection-patients-diabetes

Professor José Rodriguez Palomares co-chaired the guideline task force on 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases. Video: https://medicaldigest.org/scientific-contents/interview:2024-esc-guidelines-management-peripheral-arterial-and-aortic-diseases

Professor Iris Grunwald shares her experience of personalised stroke management. Video: https://medicaldigest.org/scientific-contents/interview:dundee-experience-really-personalised-acute-stroke-treatment

Professor Johanne Silvain presented results of the ABYSS trial in a Hot Line session at ESC Congress 2024. The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction and there was no benefit to the patients’ quality of life, according to late-breaking research presented. Video: https://medicaldigest.or...

Professor Konstantinos Toutouzas co-chaired an interresting session for general clinicians the ESC Guidelines on Cardio-Oncology and Management of Cardiovascular Disease in Patients with Diabetes. Video: https://medicaldigest.org/scientific-contents/interview:esc-clinical-practice-guidelines-2022-and-2023-general-practice-and-general-cardiology-where-do-we-stand-report-esc2024

Professor Nikolaus Marx shares his insights on patient with diabetes, heart failure with reduced ejection fraction, and impaired kidney function. How to implement the guidelines? Video: https://medicaldigest.org/scientific-contents/interview:patient-diabetes-heart-failure-reduced-ejection-fraction-and-impaired-kidney-function-how-implement-guidelines-and-take-home-messages

Professor Roser Torra shares his insigths od o ESC joint session with the European Renal Association as well as the four foundational therapies available for the treatment of DKD and the need of close collaboration between cardiologists and nephrologists. Video: https://medicaldigest.org/scientific-contents/interview:clash-titans-when-cardiovascular-and-kidney-diseases-overlap

Professor Athanasios John Manolis provides an overview of current guidelines recommendations and the importance of an individualized patient-centered approach and pathways to improve CCS future management. Video: https://medicaldigest.org/scientific-contents/interview:chronic-coronary-syndrome-journey-so-far-and-road-future

Professor Mikhail Kosiborod provides a summary of the clinical trial updates on the GLP-1 receptor agonists. Video: ⁠https://medicaldigest.org/scientific-contents/interview:clinical-trial-updates-glp-1-receptor-agonists

Principal Investigator, Professor Stefano Taddei explaining why new treatment strategies are needed for hypertension. He presented in a Hot Line session at ESC Congress 2024 how a single-pill combination of four blood-pressure-lowering medications was significantly more effective than a combination of three medications, according to late-breaking research. Video: https://medicaldigest.org/scientif...

Professor Marie-José Tassignon shares her insight on pediatric cataract surgery, she speaks about the importance of anatomical changes in the anterior interface of the eye. Video: https://medicaldigest.org/scientific-contents/standalonecontent:importance-anterior-interface-eye-surgery

Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The second part of our two-part interview - New insights in the genetics of dyslipidaemia - New data from the registries: INTERSPIRE - Anitschkow Prize & Lecture 2024: Recipient: Bart Staels - ESC/EAS Joint Symposium on risk scores, modifiers and comorbidities Video: https://medica...

Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The first part of our two-part interview covered the following topics: - Combating the triple threat: Cardiovascular disease, Diabetes mellitus, Chronic kidney disease. - Real world solutions for LDL-C management. - Can therapies alter the course of atherosclerotic cardiovascular disea...

Sytske Anne Bergstra at the recent EULAR 2024 chaired a session on the use of glucocorticoids in the therapy of rheumatoid arthritis. What were the key steps in 75 years of glucocorticoid history until they occupied their present therapeutic position? Video: https://medicaldigest.org/scientific-contents/interview:75th-anniversary-glucocorticoids-what-have-we-learnt

Professor Dennis McGonagle explains the results of an EULAR 2024 late breaking abstract, the PRO-SPIRIT study, early (3-month) and maintained (12-month) comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients. Video: https://medicaldigest.org/scientific-contents/interview:early-and-maintained-comparative-effectiveness-5-diff...

Professor Gerd Horneff explains the results of a late breaking abstract from EULAR 2024, effectiveness of canakinumab for first line steroid free treatment in systemic onset juvenile idiopathic arthritis/ juvenile Still’s disease. Video: https://medicaldigest.org/scientific-contents/interview:what-new-osteoporosis-rheumatology